The Pharmaceutical Open-Source Software Consortium Issues Request for Information Regarding Next-Generation Open-source Tool for Non-Compartmental Analysis
WASHINGTON, DC (PRWEB) May 30, 2018 -- Existing solutions for open-source software to support pharmacokinetic and/or pharmacometric applications including Non Compartmental Analysis (NCA) data management, analysis and reporting are limited with few commercial and existing open-source solutions. The Pharmaceutical Open-source Software Consortium (POSSC), a consortium involving pharmaceutical industry leaders interested in contributing to the development and delivery of an open-source based software with an initial focus for NCA, has entered a feasibility phase. The primary outcome of the feasibility phase is to evaluate the value proposition of developing a NCA platform for well controlled and regulatory compliant processing, analysis, maintenance and reporting of data and results. This phase will define user requirements, evaluation of vendor proposals, and cost-effectiveness analysis to enable a subsequent development phase of this platform.
A collaborative approach to develop an open-source NCA software will deliver a modern, robust, and flexible solution through incorporating expertise from a diverse range of pharmaceutical industry stakeholders. In addition, the collaborative framework will afford members of the Consortium the opportunity to jointly develop additional innovative software solutions for the pharmaceutical industry, beyond NCA. “There is a real need for options in this area” noted Brian Corrigan, PhD, Vice-President, Clinical Pharmacology from Pfizer, a participating company in POSSC, along with other leaders. “We have assembled an impressive team from across the pharmaceutical industry, and we are really looking forward to working together with providers to help create next-generation tools in this important area.”
POSSC has placed an open call to the vendor community by means of a “Request for Information” (RFI) through the POSSC website, https://www.possc.org/. The purposes of this RFI are to solicit interest from the vendor community in collaborating on this project and to allow vendors to learn more about the technology requirements sought by POSSC. This information will be used by POSSC to further define this project and ultimately select a vendor(s) and progress onto the next phase. It is the intention of POSSC that the new open-source tool(s) will be developed and ultimately made available to the scientific community as a platform.
We invite any vendor who may be interested in this project to participate by downloading the RFI from the POSSC website and submitting a response by the July 30, 2018 deadline. Two webinars have been scheduled on June 22 and July 17, as additional information sessions and Q&A opportunities. Webinar connection information can be found on https://www.possc.org/.
About Pharmaceutical Open-source Software Consortium: (https://www.possc.org/)
Established in 2018, the Pharmaceutical Open-source Software Consortium (POSSC) is focused on the development of innovative open-source solutions (open-source based software) for pharmacokinetic or pharmacometric applications to serve the Clinical Pharmacology and Pharmacometric Community, standardize common elements, strengthen the discipline, and ultimately bring new medicines to patients. For more information please contact the Secretariat at [email protected].
James M. Vergis, POSSC Secretariat, https://www.possc.org, +1 202-230-5439, [email protected]
Share this article